Marex Group plc (MRX), a diversified global financial services platform, today announced the pricing of its initial public offering (“IPO”) at $19.00 per share. A total of 15,384,615 common shares are being offered, of which 3,846,153 shares will be offered by Marex and 11,538,462 shares will be offered by certain selling stockholders (the “Offering Stockholders”). Marex will not receive any proceeds from the sale of shares by the selling stockholder. The common stock is expected to begin trading on the Nasdaq Global Select Market on April 25, 2024 under the ticker symbol “MRX.” The offering is expected to close on April 29, 2024, subject to customary closing conditions.
In connection with the offering, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 2,307,692 shares of common stock to cover over-allotments.
Barclays, Goldman Sachs & Company LLC, Jeffries & Keefe, Bruyette & Woods, Stifel Company, acting as joint lead bookrunning managers and representatives of the underwriters for the proposed offering. He is acting as bookrunner on the proposed offering, which includes Citigroup, UBS Investment Bank, Piper Sandler and HSBC. Drexel Hamilton and Loop Capital Markets are acting as joint managers of the proposed product.
The proposed offering will be made only by means of a prospectus. A copy of the prospectus relating to the proposed offering is available below.
- Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, phone: 1-888-603-5847, or email: barclaysprospectus@broadridge.com;
- Goldman Sachs & Co. LLC, Attn: Prospectus Division, 200 West Street, New York, New York 10282, Phone: 1-866-471-2526, or Email: Prospectus-ny@ny.email.gs.com;
- Jefferies LLC, Attention: Stock Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by telephone at (877) 821-7388, or by email. Prospectus_Department@Jefferies.com; or
- Keefe, Bruyette & Woods Inc., 787 Seventh Avenue, Fourth Floor, New York, NY 10019, Attention: Equity Capital Markets, or call toll-free (800) 966-1559 or email. USCapitalMarkets@kbw.com.
remove ads
.
A registration statement relating to these securities has been filed with and declared effective by the Securities and Exchange Commission. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor does it constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification. It does not constitute a solicitation or sale. Under the securities laws of that jurisdiction.
